查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2067419

眼科人工智慧輔助診斷市場：按組件、疾病、技術、最終用戶、國家和地區分類－產業分析、市場規模、市場佔有率及2026年至2033年預測

Ophthalmic AI-assisted Diagnosis Market, By Component, By Disease Type, By Technology, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2026-2033
出版日期: | 出版商: AnalystView Market Insights | 英文 380 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到 2025 年，人工智慧輔助眼科診斷市場規模將達到 4.902 億美元，並將在 2026 年至 2033 年期間以 21.8% 的複合年成長率成長。

眼科人工智慧輔助診斷利用電腦視覺、機器學習和深度學習等人工智慧技術分析患者數據和眼科影像，以識別、評估和後續觀察各種眼科疾病。為了快速且準確地識別異常情況，這些疾病類型會分析由眼底攝影機、光學同調斷層掃描(OCT) 系統和視網膜成像平台等診斷工具產生的資料。人工智慧驅動的診斷解決方案透過提供自動化影像分析和臨床見解，幫助眼科醫護人員減少人為因素的影響，提高診斷準確性，並實現早期介入。

眼科人工智慧輔助診斷市場—市場動態

人工智慧驅動的視網膜篩檢和早期疾病檢測的需求不斷成長，加上多模態成像技術的進步，預計將推動市場需求。

糖尿病視網膜病變、青光眼和老齡化黃斑部病變等威脅視力的疾病發生率不斷上升，顯著推動了對人工智慧驅動的眼科診斷解決方案的需求成長，進而促進了人工智慧輔助眼科診斷市場的發展。醫療機構擴大使用先進的人工智慧模型來更快、更準確地分析視網膜影像和光學同調斷層掃描掃描（OCT）影像，從而支持更早的疾病發現和更有效的臨床干預。能夠提供可靠評估結果且幾乎無需或完全無需專家支持的自主診斷系統的開發，進一步提高了大規模篩檢項目的有效性。人工智慧與雲端眼科護理平台、攜帶式影像設備和遠距眼科會診服務的整合，進一步擴大了高品質眼科護理的覆蓋範圍，尤其是在服務不足和偏遠地區。此外，有利的法規核准、數位醫療基礎設施的持續改進以及對人工智慧驅動的醫療技術投資的增加，都在加速市場應用。因此，人工智慧驅動的眼科診斷正在成為現代眼科護理中不可或缺的一部分，提高了篩檢能力、診斷準確性和整體患者療效。

深度學習演算法和眼科影像技術的持續進步顯著提升了人工智慧診斷系統的效能和臨床價值。現代人工智慧平台能夠處理和關聯來自多個資訊來源的數據，包括視網膜影像、光學同調斷層掃描（OCT）、視野檢查和電子健康記錄，從而實現更全面、更精確的疾病評估。一個關鍵的行業趨勢是多模態人工智慧解決方案的興起，這些方案整合了眼科結構和功能數據，以提高診斷準確性並支持疾病的早期檢測。此外，開發人員正擴大將「可解釋人工智慧」功能融入其中，從而提高診斷結論得出過程的透明度。這些功能有助於眼科醫師更有效地解讀人工智慧驅動的建議。

眼科人工智慧輔助診斷市場－市場區隔分析：

全球眼科人工智慧輔助診斷市場按其組成部分、疾病類型、技術、最終用戶和地區進行細分。

根據其組成部分，市場細分分為兩大類：「軟體」和「服務」。軟體領域的成長主要得益於人工智慧診斷平台的日益普及，這些平台能夠自動分析視網膜影像、光學同調斷層掃描掃描 (OCT) 影像和其他眼科資料集。醫療機構正擴大採用這些軟體解決方案，以增強篩檢能力、提高診斷準確性，並促進早期發現糖尿病視網膜病變、青光眼和老齡化黃斑部病變等威脅視力的疾病。人工智慧軟體能夠簡化臨床工作流程、減少診斷差異並提供數據驅動的快速洞察，這進一步推動了該領域的需求成長。

依疾病類型，眼科人工智慧輔助診斷市場可分為七大類：糖尿病視網膜病變、青光眼、白內障、視網膜疾病、角膜疾病、老齡化黃斑部病變及其他。糖尿病視網膜病變細分市場在眼科人工智慧輔助診斷市場中佔據較大佔有率，這主要得益於全球糖尿病盛行率的上升以及對定期視網膜篩檢需求的增加。糖尿病視網膜病變是工作年齡人口失明和視力障礙最常見的原因之一。早期發現和持續後續觀察對於降低嚴重視力障礙的風險至關重要。因此，能夠有效早期檢測視網膜異常的人工智慧診斷工具的應用日益廣泛，從而改善患者預後和疾病管理。

眼科人工智慧輔助診斷市場—區域分析

北美在眼科人工智慧輔助診斷市場佔據重要地位，這得益於其完善的醫療保健基礎設施、廣泛應用的數位化醫療解決方案以及對人工智慧和先進眼科成像技術的巨額投資。針對糖尿病視網膜病變、青光眼和老齡化黃斑部病變部病變等疾病的人工智慧篩檢工具在該地區透過遠距眼科計畫、專科眼科診所和醫院廣泛應用。此外，根據美國疾病管制與預防中心（CDC）統計，超過3,800萬美國人患有糖尿病，凸顯了定期進行視網膜篩檢和早期診斷眼科疾病的重要性。

在歐洲，眼科人工智慧輔助診斷市場正穩步成長，這主要得益於對眼科疾病早期檢測的日益重視、人口快速老化以及人工智慧臨床決策支援解決方案的廣泛應用。該地區的醫療機構正投資於先進的視網膜成像系統和新一代人工智慧平台，這些平台能夠分析包括光學相干斷層掃描（OCT）掃描、眼底照片和患者健康記錄在內的多種資料來源，從而提高診斷的準確性和效率。一個值得關注的趨勢是，醫療機構、研究機構和科技公司之間正在加強合作，共同開發創新的基於人工智慧的眼科診斷工具。

目錄

第1章：眼科人工智慧輔助診斷市場概述

  • 分析範圍
  • 市場估算期

第2章執行摘要

  • 市場區隔
  • 競爭考察

第3章：眼科人工智慧輔助診斷的關鍵市場趨勢

  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 未來市場趨勢

第4章：人工智慧輔助眼科診斷的產業分析

  • PEST分析
  • 波特五力分析
  • 市場成長前景展望圖
  • 管理體制分析

第5章：人工智慧輔助眼科診斷市場：地緣政治緊張局勢加劇的影響

  • 新冠疫情的影響
  • 俄烏戰爭的影響
  • 中東衝突的影響

第6章：眼科人工智慧輔助診斷的市場趨勢

  • 2025年人工智慧輔助眼科診斷市場佔有率分析
  • 主要製造商的細分數據
    • 對現有公司的分析
    • 新興企業分析

第7章：眼科人工智慧輔助診斷市場：按組件分類

  • 概述
    • 基於細分市場的市場佔有率分析：按組件
    • 軟體
      • 人工智慧診斷軟體
      • 臨床支援系統
      • 其他
    • 服務

第8章：眼科人工智慧輔助診斷市場：依疾病類型分類

  • 概述
    • 基於細分市場的市場佔有率分析：按疾病類型
    • 糖尿病視網膜病變
    • 青光眼
    • 白內障
    • 視網膜疾病
    • 角膜疾病
    • 老齡化黃斑部病變
    • 其他

第9章：眼科人工智慧輔助診斷市場：依技術分類

  • 概述
    • 基於細分市場的市場佔有率分析：按技術分類
    • 機器學習
    • 電腦視覺
    • 自然語言處理（NLP）
    • 其他

第10章：眼科人工智慧輔助診斷市場：依最終使用者分類

  • 概述
    • 基於細分市場的市場佔有率分析：按最終用戶分類
    • 醫院
    • 門診手術中心
    • 診斷和影像中心
    • 學術研究
    • 其他

第11章：眼科人工智慧輔助診斷市場：按地區分類

  • 介紹
  • 北美洲
    • 概述
    • 主要製造商：北美
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 主要製造商：歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 瑞典
    • 俄羅斯
    • 波蘭
    • 其他歐洲國家
  • 亞太地區
    • 概述
    • 主要製造商：亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 菲律賓
    • 其他亞太國家
  • 拉丁美洲
    • 概述
    • 主要製造商：拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 其他拉丁美洲國家
  • 中東和非洲
    • 概述
    • 主要生產商：中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • 其他中東和非洲國家

第12章：主要供應商分析：眼科人工智慧輔助診斷產業

  • 競爭對手儀錶板
    • 競爭基準
    • 競爭定位
  • 公司簡介
    • Topcon Healthcare
    • Carl Zeiss Meditec
    • Heidelberg Engineering
    • Digital Diagnostics
    • Eyenuk
    • Optomed
    • NIDEK Co., Ltd.
    • Canon Medical Systems
    • Altris AI
    • AEYE Health
    • Canon, Inc.
    • Essilor Instruments
    • RetInSight
    • Kowa Company Ltd.
    • Optos
    • Others

第13章：AnalystView 的全景視圖

簡介目錄
Product Code: ANV6704

Ophthalmic AI-assisted Diagnosis Market size was valued at USD 490.2 Million in 2025, expanding to a CAGR of 21.8% from 2026 to 2033.

Ophthalmic AI-assisted diagnosis involves the use of artificial intelligence technologies, including computer vision, machine learning, and deep learning, to analyze patient data and ophthalmic pictures in order to identify, evaluate, and track a variety of eye disorders. In order to promptly and precisely identify anomalies, these disease types examine data produced by diagnostic tools such as fundus cameras, optical coherence tomography (OCT) systems, and retinal imaging platforms. AI-powered diagnostic solutions help eye care providers reduce human variability, increase diagnostic accuracy, and enable earlier intervention by offering automated picture interpretation and clinical insights.

Ophthalmic AI-assisted Diagnosis Market- Market Dynamics

Increasing demand from AI-assisted retinal screening, early disease detection and advancement in multimodal imaging are expected to propel market demand

The growing incidence of sight-threatening conditions, including diabetic retinopathy, glaucoma, and age-related macular degeneration, is significantly increasing the demand for AI-enabled ophthalmic diagnostic solutions, boosting ophthalmic AI-assisted diagnosis market growth. Healthcare organizations are increasingly leveraging advanced AI models to analyze retinal images and optical coherence tomography (OCT) scans with enhanced speed and accuracy, supporting earlier disease detection and more effective clinical intervention. Large-scale screening programs are now more effective because to recent advancements that have produced autonomous diagnostic systems that can produce trustworthy evaluations with little assistance from specialists. Access to high-quality eye care is being further expanded by the integration of AI with cloud-based eye care platforms, portable imaging equipment, and teleophthalmology services, especially in underserved and remote locations. Furthermore, market adoption is being accelerated by favorable regulatory clearances, ongoing improvements in digital health infrastructure, and growing investments in AI-driven healthcare technology. As a result, AI-assisted ophthalmic diagnosis is becoming an essential component of modern eye care, enhancing screening capacity, diagnostic accuracy, and overall patient outcomes.

Continuous advancements in deep learning algorithms and ophthalmic imaging technologies are significantly improving the performance and clinical value of AI-assisted diagnostic systems. Modern AI platforms are capable of processing and correlating data from multiple sources, including retinal images, optical coherence tomography (OCT) scans, visual field assessments, and electronic health records, enabling more comprehensive and accurate disease evaluation. A major industry trend is the emergence of multimodal AI solutions that integrate both structural and functional ocular data to enhance diagnostic precision and support earlier disease detection. In addition, developers are increasingly incorporating explainable AI capabilities that provide greater transparency into how diagnostic conclusions are generated. These features help ophthalmologists interpret AI-driven recommendations more effectively.

Ophthalmic AI-assisted Diagnosis Market- Segmentation Analysis:

The Global Ophthalmic AI-assisted Diagnosis Market is segmented on the basis of Component, Disease Type, Technology, End User, and Region.

The market is divided into two categories based on Component: Software and services. software segment growth is primarily attributed to the rising adoption of AI-enabled diagnostic platforms capable of automatically analyzing retinal images, optical coherence tomography (OCT) scans, and other ophthalmic datasets. Healthcare institutions are increasingly deploying these software solutions to enhance screening capabilities, improve diagnostic precision, and facilitate the early identification of vision-threatening conditions, including diabetic retinopathy, glaucoma, and age-related macular degeneration. The ability of AI software to streamline clinical workflows, reduce diagnostic variability, and deliver rapid, data-driven insights is further fueling segment demand.

The market is divided into seven categories based on Disease Type: diabetic retinopathy, glaucoma, cataracts, retina disorders, corneal disorders, age-related macular degeneration, and others. The diabetic retinopathy segment represents significant share of the ophthalmic AI-assisted diagnosis market, largely due to the rising prevalence of diabetes worldwide and the growing demand for routine retinal screening. Diabetic retinopathy is one of the most prevalent causes of blindness and vision impairment in people of working age. To reduce the risk of serious visual consequences, it must be identified early and monitored continuously. This has led to a rise in the use of AI-powered diagnostic tools that can effectively spot retinal abnormalities early on, improving patient outcomes and disease management.

Ophthalmic AI-assisted Diagnosis Market- Geographical Insights

North America holds a key position in the ophthalmic AI-assisted diagnosis market, driven by its well-established healthcare infrastructure, widespread adoption of digital healthcare solutions, and substantial investments in artificial intelligence and advanced ophthalmic imaging technologies. AI-enabled screening tools for diseases like diabetic retinopathy, glaucoma, and age-related macular degeneration have been widely used in the area by teleophthalmology programs, specialty eye care facilities, and hospitals. Furthermore, according to the Centres for Disease Control and Prevention (CDC), over 38 million Americans have diabetes, which indicates the critical need for routine retinal screenings and early diagnosis of eye diseases.

Europe is witnessing consistent growth in the ophthalmic AI-assisted diagnosis market, driven by the increasing emphasis on early detection of eye diseases, a rapidly aging population, and the expanding use of AI-powered clinical decision-support solutions. Healthcare organizations across the region are investing in advanced retinal imaging systems and next-generation AI platforms that can analyze multiple data sources, including OCT scans, fundus photographs, and patient health records, to improve diagnostic accuracy and efficiency. A notable trend is the growing collaboration between healthcare providers, research institutions, and technology companies to develop innovative AI-based ophthalmic diagnostic tools.

Germany Ophthalmic AI-assisted Diagnosis Market- Key Insights

Germany is among the most prominent markets for ophthalmic AI-assisted diagnosis in Europe, driven by its highly developed healthcare infrastructure, robust medical technology industry, and ongoing investments in healthcare digitalization. Market growth is being fueled by the increasing incidence of age-related vision disorders, diabetes-associated retinal diseases, and a growing elderly population that requires frequent eye screenings and continuous disease management.

Healthcare institutions and ophthalmology clinics across Germany are progressively implementing AI-enabled retinal imaging solutions and optical coherence tomography (OCT)-based diagnostic platforms to enhance diagnostic precision, improve workflow efficiency, and facilitate earlier detection of ocular conditions. Furthermore, Germany's extensive ecosystem of academic medical centers, research organizations, and healthcare technology companies is supporting the advancement, clinical validation, and commercialization of innovative AI-driven ophthalmic diagnostic tools.

Ophthalmic AI-assisted Diagnosis Market- Competitive Landscape:

The ophthalmic AI-assisted diagnosis market is characterized by intense competition, with participation from leading ophthalmic equipment manufacturers, healthcare technology providers, artificial intelligence specialists, and innovative digital health startups. Companies are making significant investments in the creation of advanced artificial intelligence (AI) systems that can correctly interpret retinal images, optical coherence tomography (OCT) scans, visual field evaluations, and other ophthalmic data. Efforts to improve diagnostic accuracy, increase the number of eye illnesses that may be detected, obtain regulatory clearances, and smoothly incorporate AI-powered solutions into routine clinical practice are rapidly shaping the competitive environment. Market participants are also concentrating on increasing the effectiveness of workflows, facilitating the early diagnosis of diseases, and providing scalable diagnostic technologies that facilitate both in-clinic and remote ophthalmic treatment, among other things.

Strategic collaborations between ophthalmology device manufacturers, healthcare providers, research institutions, and AI software companies are accelerating innovation and commercialization across the ophthalmic AI-assisted diagnosis market. For example, Digital Diagnostics developed the autonomous AI system IDx-DR, which received regulatory approval for the detection of diabetic retinopathy and demonstrated the growing clinical acceptance of AI-driven eye disease screening.

Recent Developments:

In 2025, Carl Zeiss Meditec expanded its AI-enabled ophthalmology capabilities with the introduction of the ZEISS Research Data Platform, a cloud-based solution developed to enhance ophthalmic research and support data-driven diagnostic innovation. The platform enables the integration of clinical and research data from multiple sources, facilitating advanced AI-powered analytics, etc.

In 2025, Topcon Healthcare enhanced its AI-powered ophthalmology portfolio through the acquisition of RetInSight, a company specializing in artificial intelligence solutions for retinal imaging. The acquisition expanded Topcon's capabilities in AI-assisted optical coherence tomography (OCT) analysis, enabling more accurate detection, assessment, and monitoring of retinal conditions, including neovascular age-related macular degeneration, diabetic macular edema, and retinal vascular disorders.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL OPHTHALMIC AI-ASSISTED DIAGNOSIS MARKET KEY PLAYERS

  • Topcon Healthcare
  • Carl Zeiss Meditec
  • Heidelberg Engineering
  • Digital Diagnostics
  • Eyenuk
  • Optomed
  • NIDEK Co., Ltd.
  • Canon Medical Systems
  • Altris AI
  • AEYE Health
  • Canon, Inc.
  • Essilor Instruments
  • RetInSight
  • Kowa Company Ltd.
  • Optos
  • Others

GLOBAL OPHTHALMIC AI-ASSISTED DIAGNOSIS MARKET, BY COMPONENT- MARKET ANALYSIS, 2020-2033

  • Software
  • AI Diagnostic Software
  • Clinical Support System
  • Others
  • Services

GLOBAL OPHTHALMIC AI-ASSISTED DIAGNOSIS MARKET, BY DISEASE TYPE- MARKET ANALYSIS, 2020-2033

  • Diabetic retinopathy
  • Glaucoma
  • Cataracts
  • Retina disorders
  • Corneal disorders
  • Age-related macular degeneration
  • Others

GLOBAL OPHTHALMIC AI-ASSISTED DIAGNOSIS MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2020-2033

  • Machine Learning
  • Computer Vision
  • Natural Language Processing (NLP)
  • Others

GLOBAL OPHTHALMIC AI-ASSISTED DIAGNOSIS MARKET, BY END USER- MARKET ANALYSIS, 2020-2033

  • Hospitals
  • Ambulatory Surgical Centers
  • Diagnostic & Imaging Centers
  • Academic Research
  • Others

GLOBAL OPHTHALMIC AI-ASSISTED DIAGNOSIS MARKET, BY REGION- MARKET ANALYSIS, 2020-2033

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Ophthalmic AI-assisted Diagnosis Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Ophthalmic AI-assisted Diagnosis Market Snippet by Component
    • 2.1.2. Ophthalmic AI-assisted Diagnosis Market Snippet by Disease Type
    • 2.1.3. Ophthalmic AI-assisted Diagnosis Market Snippet by Technology
    • 2.1.4. Ophthalmic AI-assisted Diagnosis Market Snippet by End User
    • 2.1.5. Ophthalmic AI-assisted Diagnosis Market Snippet by Country
    • 2.1.6. Ophthalmic AI-assisted Diagnosis Market Snippet by Region
  • 2.2. Competitive Insights

3. Ophthalmic AI-assisted Diagnosis Key Market Trends

  • 3.1. Ophthalmic AI-assisted Diagnosis Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Ophthalmic AI-assisted Diagnosis Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Ophthalmic AI-assisted Diagnosis Market Opportunities
  • 3.4. Ophthalmic AI-assisted Diagnosis Market Future Trends

4. Ophthalmic AI-assisted Diagnosis Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Ophthalmic AI-assisted Diagnosis Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Ophthalmic AI-assisted Diagnosis Market Landscape

  • 6.1. Ophthalmic AI-assisted Diagnosis Market Share Analysis, 2025
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Ophthalmic AI-assisted Diagnosis Market - By Component

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Component, 2025 & 2033 (%)
    • 7.1.2. Software
      • 7.1.2.1. AI Diagnostic Software
      • 7.1.2.2. Clinical Support System
      • 7.1.2.3. Others
    • 7.1.3. Services

8. Ophthalmic AI-assisted Diagnosis Market - By Disease Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Disease Type, 2025 & 2033 (%)
    • 8.1.2. Diabetic retinopathy
    • 8.1.3. Glaucoma
    • 8.1.4. Cataracts
    • 8.1.5. Retina disorders
    • 8.1.6. Corneal disorders
    • 8.1.7. Age-related macular degeneration
    • 8.1.8. Others

9. Ophthalmic AI-assisted Diagnosis Market - By Technology

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Technology, 2025 & 2033 (%)
    • 9.1.2. Machine Learning
    • 9.1.3. Computer Vision
    • 9.1.4. Natural Language Processing (NLP)
    • 9.1.5. Others

10. Ophthalmic AI-assisted Diagnosis Market - By End User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End User, 2025 & 2033 (%)
    • 10.1.2. Hospitals
    • 10.1.3. Ambulatory Surgical Centers
    • 10.1.4. Diagnostic & Imaging Centers
    • 10.1.5. Academic Research
    • 10.1.6. Others

11. Ophthalmic AI-assisted Diagnosis Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Ophthalmic AI-assisted Diagnosis Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Ophthalmic AI-assisted Diagnosis Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.3.9. UK
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.9.3. UK Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.3.9.4. UK Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
      • 11.3.9.5. UK Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.3.9.6. UK Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.3.10. France
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.10.3. France Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.3.10.4. France Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
      • 11.3.10.5. France Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.3.10.6. France Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.3.11. Italy
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.11.3. Italy Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.3.11.4. Italy Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
      • 11.3.11.5. Italy Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.3.11.6. Italy Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.3.12. Spain
      • 11.3.12.1. Overview
      • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.12.3. Spain Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.3.12.4. Spain Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
      • 11.3.12.5. Spain Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.3.12.6. Spain Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.3.13. The Netherlands
      • 11.3.13.1. Overview
      • 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.13.3. The Netherlands Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.3.13.4. The Netherlands Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
      • 11.3.13.5. The Netherlands Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.3.13.6. The Netherlands Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Overview
      • 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.3.14.6. Sweden Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.3.15. Russia
      • 11.3.15.1. Overview
      • 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.15.3. Russia Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.3.15.4. Russia Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
      • 11.3.15.5. Russia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.3.15.6. Russia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.3.16. Poland
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.16.3. Poland Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.3.16.4. Poland Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
      • 11.3.16.5. Poland Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.3.16.6. Poland Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.3.17. Rest of Europe
      • 11.3.17.1. Overview
      • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.17.3. Rest of the Europe Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.3.17.4. Rest of the Europe Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
      • 11.3.17.5. Rest of the Europe Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.3.17.6. Rest of the Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Ophthalmic AI-assisted Diagnosis Key Manufacturers in Asia Pacific
    • 11.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 11.4.4. APAC Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
    • 11.4.5. APAC Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
    • 11.4.6. APAC Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.4.7. APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.4.8. China
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.8.3. China Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.4.8.4. China Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
      • 11.4.8.5. China Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.4.8.6. China Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.4.9. India
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.9.3. India Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.4.9.4. India Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
      • 11.4.9.5. India Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.4.9.6. India Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.4.13. Indonesia
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.13.3. Indonesia Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.4.13.4. Indonesia Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
      • 11.4.13.5. Indonesia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.4.13.6. Indonesia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.4.14. Thailand
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.14.3. Thailand Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.4.14.4. Thailand Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
      • 11.4.14.5. Thailand Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.4.14.6. Thailand Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.5. Latin America (LATAM)
    • 11.5.1. Overview
    • 11.5.2. Ophthalmic AI-assisted Diagnosis Key Manufacturers in Latin America
    • 11.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 11.5.4. LATAM Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
    • 11.5.5. LATAM Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
    • 11.5.6. LATAM Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.5.7. LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.6. Middle East and Africa (MEA)
    • 11.6.1. Overview
    • 11.6.2. Ophthalmic AI-assisted Diagnosis Key Manufacturers in Middle East and Africa
    • 11.6.3. MEA Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 11.6.4. MEA Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
    • 11.6.5. MEA Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
    • 11.6.6. MEA Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.6.7. MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)

12. Key Vendor Analysis- Ophthalmic AI-assisted Diagnosis Industry

  • 12.1. Competitive Dashboard
    • 12.1.1. Competitive Benchmarking
    • 12.1.2. Competitive Positioning
  • 12.2. Company Profiles
    • 12.2.1. Topcon Healthcare
    • 12.2.2. Carl Zeiss Meditec
    • 12.2.3. Heidelberg Engineering
    • 12.2.4. Digital Diagnostics
    • 12.2.5. Eyenuk
    • 12.2.6. Optomed
    • 12.2.7. NIDEK Co., Ltd.
    • 12.2.8. Canon Medical Systems
    • 12.2.9. Altris AI
    • 12.2.10. AEYE Health
    • 12.2.11. Canon, Inc.
    • 12.2.12. Essilor Instruments
    • 12.2.13. RetInSight
    • 12.2.14. Kowa Company Ltd.
    • 12.2.15. Optos
    • 12.2.16. Others

13. 360 Degree AnalystView

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us